NanoViricides Restructures Agreements to Alleviate Financial Stress

TipRanksFeb 17 06:03

EF Hutton Reiterates Buy on Nanoviricides, Maintains $6.5 Price Target

EF Hutton analyst Tim Moore reiterates Nanoviricides (AMEX:NNVC) with a Buy and maintains $6.5 price target.

BenzingaFeb 16 20:14

Nanoviricides Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 02/16/2024 470.18% EF Hutton → $6.5 Reiterates Buy → Buy 06/01/2023 360.53% EF Hutton → $5.25 Assumes → Bu

BenzingaFeb 16 20:13

Nanoviricides Q2 EPS $(0.18) Down From $(0.15) YoY; As Of December 31, 2023, We Had Cash And Cash Equivalent Current Assets Balance Of Approximately $5.31M. Additional Agreements Have Resulted In A Further Approximately $2.5M Available Cash

Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.18) per share. This is a 20 percent decrease over losses of $(0.15) per share from the same period last year.

BenzingaFeb 15 19:44

NanoViricides GAAP EPS of -$0.18

Seeking AlphaFeb 15 19:38

NanoViricides Reports Positive Safety Results for COVID Drug Candidate

Seeking AlphaJan 30 01:52